MétaCan
Menu
← Back to cohort
Record W7104384641 · doi:10.5281/zenodo.17548314

Pharmacogenomics and Pregnancy Pharmacokinetics: Toward Precision Drug Therapy in Obstetrics

2025· article· en· W7104384641 on OpenAlexaff

Bibliographic record

VenueZenodo (CERN European Organization for Nuclear Research) · 2025
Typearticle
Languageen
FieldMedicine
TopicPregnancy and Medication Impact
Canadian institutionsAlberta Children's Hospital
Fundersnot available
KeywordsPharmacogenomicsPregnancyPharmacotherapyPharmacogeneticsPharmacokineticsDrugPrecision medicineTherapeutic drug monitoring

Abstract

fetched live from OpenAlex

Background: Pregnancy profoundly reshapes drug disposition through physiologic changes in absorption, distribution, metabolism, and excretion. Maternal, placental, and fetal genomes add additional layers of variability, creating challenges for safe and effective pharmacotherapy in obstetrics. Objective: To synthesize current evidence on how pharmacogenomics and pregnancy related pharmacokinetics can be integrated to optimize drug therapy in obstetrics, and to highlight clinical, safety, and research implications. Methodology: This narrative review draws from clinical guidelines (e.g., CPIC, ACOG, FDA), systematic assessments, pharmacokinetic and pharmacogenomic studies, and implementation reports. Key therapeutic domains were examined, including analgesia/anesthesia, antiepileptics, antimicrobials, and antidepressants, with a focus on pregnancy induced pharmacokinetic remodeling and genotype driven variability. Results: Pregnancy increases CYP2D6 and CYP3A activity, decreases CYP1A2 activity, and enhances glucuronidation, leading to altered drug exposure that may mask or amplify pharmacogenomic effects. Clinically, CYP2D6 genotype significantly impacts opioid safety in the peripartum and lactation period, while HLA-B15:02 and HLA-A31:01 genotypes strongly predict carbamazepine/oxcarbazepine induced cutaneous reactions. NAT2 polymorphisms modify isoniazid metabolism and toxicity risk, while CYP2C9 and UGT variants influence sulfamethoxazole exposure. CYP2C19 and CYP2D6 variants affect antidepressant efficacy and tolerability, with pregnancy further altering drug clearance. Implementation studies demonstrate that pre-emptive pharmacogenomic testing (e.g., HLA genotyping in Thailand) reduces adverse outcomes, while clinical decision support tools facilitate translation into practice. Conclusion: Pharmacogenomics, when combined with the physiologic realities of pregnancy and lactation, provides a pathway toward precision pharmacotherapy in obstetrics. High-value opportunities already exist, including avoidance of CYP2D6-dependent prodrugs in breastfeeding and pre-emptive HLA testing for carbamazepine/oxcarbazepine. Future priorities include integrating maternal–placental–fetal genomics, developing pregnancy-specific dosing algorithms, and ensuring equitable implementation across diverse populations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.020
metaresearch head score (Gemma)0.050
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.020
Threshold uncertainty score0.104

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0200.050
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.003
Bibliometrics0.0020.002
Science and technology studies0.0000.002
Scholarly communication0.0040.004
Open science0.0010.002
Research integrity0.0020.004
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.047
GPT teacher head0.314
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueZenodo (CERN European Organization for Nuclear Research)→Same topicPregnancy and Medication Impact→French-language works237,207→